112 related articles for article (PubMed ID: 21087977)
21. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia.
Josiassen RC; Goldman M; Jessani M; Shaughnessy RA; Albazzaz A; Lee J; Ouyang J; Orlandi C; Czerwiec F
Biol Psychiatry; 2008 Dec; 64(12):1097-100. PubMed ID: 18692175
[TBL] [Abstract][Full Text] [Related]
22. Hyponatremia in psychiatric patients: update on evaluation and management.
Siegel AJ
Harv Rev Psychiatry; 2008; 16(1):13-24. PubMed ID: 18306096
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Ferguson JW; Therapondos G; Newby DE; Hayes PC
Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
Gross AJ; Steinberg SM; Reilly JG; Bliss DP; Brennan J; Le PT; Simmons A; Phelps R; Mulshine JL; Ihde DC
Cancer Res; 1993 Jan; 53(1):67-74. PubMed ID: 8380126
[TBL] [Abstract][Full Text] [Related]
25. Tolvaptan: any evidence of efficacy in SIADH?
Prescrire Int; 2010 Oct; 19(109):197-200. PubMed ID: 21180368
[TBL] [Abstract][Full Text] [Related]
26. [A case of long-term survival in a patient with small cell lung carcinoma with syndrome of inappropriate secretion of anti-diuretic hormone].
Hoshino H; Nakano H; Minato K; Ezawa K; Fueki N; Takei Y; Naruse I; Nomoto T; Makimoto T; Kurihara M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):127-31. PubMed ID: 8385718
[TBL] [Abstract][Full Text] [Related]
27. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Patel GP; Balk RA
Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
[TBL] [Abstract][Full Text] [Related]
28. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.
Gerbes AL; Gülberg V; Ginès P; Decaux G; Gross P; Gandjini H; Djian J;
Gastroenterology; 2003 Apr; 124(4):933-9. PubMed ID: 12671890
[TBL] [Abstract][Full Text] [Related]
29. [Practical approach to hyponatremia].
Gross P; Benzing T; Hensen J; Mönig H
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1728-32. PubMed ID: 21877305
[No Abstract] [Full Text] [Related]
30. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer.
Iyer AV; Krasnow SH; Dufour DR; Arcenas AS
Clin Lung Cancer; 2003 Nov; 5(3):187-9. PubMed ID: 14667276
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
[TBL] [Abstract][Full Text] [Related]
32. The vaptans: just landed. But how was the trip?
Gross P
Nephrol Dial Transplant; 2010 May; 25(5):1367-8. PubMed ID: 20200008
[No Abstract] [Full Text] [Related]
33. Hypouricemia, inappropriate secretion of antidiuretic hormone, and small cell carcinoma of the lung.
Passamonte PM
Arch Intern Med; 1984 Aug; 144(8):1569-70. PubMed ID: 6087754
[TBL] [Abstract][Full Text] [Related]
34. Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
Kazama I; Arata T; Michimata M; Hatano R; Suzuki M; Miyama N; Sanada S; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Nephrol Dial Transplant; 2007 Jan; 22(1):68-76. PubMed ID: 16702208
[TBL] [Abstract][Full Text] [Related]
35. Thymic neuroblastoma with the syndrome of inappropriate secretion of antidiuretic hormone.
Ogawa F; Amano H; Iyoda A; Satoh Y
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):903-5. PubMed ID: 19661118
[TBL] [Abstract][Full Text] [Related]
36. The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
Kusuki M; Iguchi H; Nakamura A; Nishiura H; Kanazawa A; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):74-7. PubMed ID: 15513517
[TBL] [Abstract][Full Text] [Related]
37. Use of conivaptan for refractory syndrome of inappropriate secretion of antidiuretic hormone in a pediatric patient.
Peters S; Kuhn R; Gardner B; Bernard P
Pediatr Emerg Care; 2013 Feb; 29(2):230-2. PubMed ID: 23546432
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Mao ZL; Stalker D; Keirns J
Clin Ther; 2009 Jul; 31(7):1542-50. PubMed ID: 19695403
[TBL] [Abstract][Full Text] [Related]
39. Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer.
Garrahy A; Hannon AM; Zia-Ul-Hussnain HM; Williams DJ; Thompson CJ
Eur J Clin Pharmacol; 2018 Feb; 74(2):245-246. PubMed ID: 29147803
[No Abstract] [Full Text] [Related]
40. [Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma].
Soria JC; Fizazi K; Merad M; Le Chevalier T
Bull Cancer; 1996 Aug; 83(8):605-8. PubMed ID: 8869039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
